Latest Cellular Dynamics International (ICEL) Head
Post# of 26
Posted On: 03/12/2014 10:17:47 PM
Latest Cellular Dynamics International (ICEL) Headlines
Cellular Dynamics International Reports Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Mon Mar 10, 3:40PM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the fourth quarter and for the fiscal year ended December 31, 2013.
Cellular Dynamics to Host Fourth Quarter and Full Year 2013 Financial Results Webcast and Call
GlobeNewswire - Tue Feb 25, 3:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that the company will host a webcast and conference call to discuss its financial results for the fourth quarter and for the fiscal year ended December 31, 2013.
Cellular Dynamics to Present at the Cowen Group's 34th Annual Health Care Conference
GlobeNewswire - Mon Feb 24, 3:49PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Cowen Group's 34 Annual Health Care Conference at 3:30 p.m. EST, Monday, March 3, in Boston.
Cellular Dynamics International, Inc.Corporate Event Announcement Notice
Wall Street Horizon - Wed Feb 19, 8:07PM CST
Airline announces new flights in Alberta and Saskatchewan
Cellular Dynamics to Present at Leerink Swann Global Healthcare Conference
GlobeNewswire - Thu Feb 06, 3:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink Swann Global Healthcare Conference at 3:30 p.m. EST, Wednesday, February 12, in New York City.
Nasdaq stocks posting largest percentage decreases
AP - Tue Jan 21, 12:56PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives
ACCESSWIRE - Mon Jan 13, 9:09AM CST
Thanks to new legislation being approved by the Upper House of Japan's Parliament in November, Japan's so-called "drug lag," specifically with respect to regenerative medicine, will likely become a thing of the past. By retooling the framework of the regulatory process for regenerative medicine products, the nation has shifted from a global drug development laggard to one of the most proactive countries on the planet aiming to safely expedite growth in the burgeoning, yet volatile, stem cell industry to meet the needs of a rapidly expanding aging population. The new laws are designed to promote innovation and could provide a clear channel to rapid commercialization that will benefit industry-leading companies like Cellular Dynamics International, Inc. (NASDAQ: ICEL), Athersys, Inc. (NASDAQ: ATHX) and Cytori Therapeutics, Inc. (NASDAQ: CYTX).
Cellular Dynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Fri Jan 10, 7:00AM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the 32 Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PST, Tuesday, January 14, at the Westin St. Francis Hotel in San Francisco.
Why You Must Watch Nestlé SA, Cellular Dynamics International Inc., AstraZeneca plc (ADR), and Arthr
Leo Sun, The Motley Fool - Motley Fool - Wed Jan 08, 6:58AM CST
Follow @leokornsun // full story)
Cellular Dynamics International to supply iCell and MyCell Products to NIHS for nutritional research
M2 - Wed Jan 08, 5:17AM CST
Stem cell technologies company Cellular Dynamics International (NasdaqGM:ICEL) revealed on Wednesday the execution of long-term supply agreement with the Nestle Institute of Health Sciences SA (NIHS) for an undisclosed amount.
Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research
Thomson Reuters ONE - Wed Jan 08, 1:00AM CST
MADISON, Wis., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced signing a long-term supply agreement with the Nestle Institute of Health Sciences SA (NIHS). Terms of the agreement were not disclosed.
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 16, 7:05AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 23, 2013.
The Hamner Institutes for Health Sciences partners with Cellular Dynamics to develop in vitro assays using human iPS cell-derived hepatocytes
M2 - Tue Dec 10, 4:49AM CST
Stem cell technologies company Cellular Dynamics International (NasdaqGM:CDI) reported on Monday the launch of a collaborative agreement to develop predictive in vitro screening assays for chemical, environmental and pharmaceutical toxicology assessments that utilise its human induced pluripotent stem (iPS) cell-derived hepatocytes.
The Hamner Institutes and Cellular Dynamics Collaborate to Develop In Vitro Assays Using Human iPS Cell-Derived Hepatocytes
GlobeNewswire - Mon Dec 09, 7:00AM CST
The Hamner Institutes for Health Sciences today announced a collaborative agreement with Cellular Dynamics International (CDI) to develop predictive in vitro screening assays for chemical, environmental and pharmaceutical toxicology assessments that utilize CDI's human induced pluripotent stem (iPS) cell-derived hepatocytes.
Jain Foundation Signs Agreement With Cellular Dynamics to Create iPSC Lines From Patients With Muscular Dystrophies
GlobeNewswire - Wed Dec 04, 7:00AM CST
The Jain Foundation, a non-profit organization whose mission is to cure muscular dystrophies caused by dysferlin protein deficiency, today announced the signing of a Master Service Agreement with Cellular Dynamics International (CDI) (Nasdaq:ICEL). CDI will create five induced pluripotent stem cell (iPSC) lines from patients with these dystrophies. As there are currently no effective treatments for these genetic disorders, establishing model iPSC lines is an important step toward developing new drugs and therapies for these patients. Terms of the agreement were not disclosed.
Cellular Dynamics International Reports Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 3:05PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the third quarter ended September 30, 2013.
Cellular Dynamics International Announces Conference Call to Discuss Third Quarter 2013 Financial and Operating Results
GlobeNewswire - Tue Nov 05, 7:00AM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced that it will report third quarter 2013 financial and operating results after the close of U.S. financial markets on November 12, 2013. Bob Palay, chairman of the board and chief executive officer of CDI, will host a conference call and webcast at 8:00 a.m. EST, November 13, 2013.
Cellular Dynamics Receives Formal Notice of Grant Award (NGA) for $16 Million Stem Cell Banking Project
GlobeNewswire - Mon Nov 04, 3:05PM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) announced today that the company has received the Notice of Grant Award (NGA) from the California Institute of Regenerative Medicine (CIRM) to create a human induced pluripotent stem cell (iPSC) biobank from 3,000 individuals. Receipt of the NGA signifies the entry into a definitive agreement with CIRM and the initiation of funding for the $16 million project.
Cellular Dynamics International Reports Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Mon Mar 10, 3:40PM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the fourth quarter and for the fiscal year ended December 31, 2013.
Cellular Dynamics to Host Fourth Quarter and Full Year 2013 Financial Results Webcast and Call
GlobeNewswire - Tue Feb 25, 3:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that the company will host a webcast and conference call to discuss its financial results for the fourth quarter and for the fiscal year ended December 31, 2013.
Cellular Dynamics to Present at the Cowen Group's 34th Annual Health Care Conference
GlobeNewswire - Mon Feb 24, 3:49PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Cowen Group's 34 Annual Health Care Conference at 3:30 p.m. EST, Monday, March 3, in Boston.
Cellular Dynamics International, Inc.Corporate Event Announcement Notice
Wall Street Horizon - Wed Feb 19, 8:07PM CST
Airline announces new flights in Alberta and Saskatchewan
Cellular Dynamics to Present at Leerink Swann Global Healthcare Conference
GlobeNewswire - Thu Feb 06, 3:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink Swann Global Healthcare Conference at 3:30 p.m. EST, Wednesday, February 12, in New York City.
Nasdaq stocks posting largest percentage decreases
AP - Tue Jan 21, 12:56PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives
ACCESSWIRE - Mon Jan 13, 9:09AM CST
Thanks to new legislation being approved by the Upper House of Japan's Parliament in November, Japan's so-called "drug lag," specifically with respect to regenerative medicine, will likely become a thing of the past. By retooling the framework of the regulatory process for regenerative medicine products, the nation has shifted from a global drug development laggard to one of the most proactive countries on the planet aiming to safely expedite growth in the burgeoning, yet volatile, stem cell industry to meet the needs of a rapidly expanding aging population. The new laws are designed to promote innovation and could provide a clear channel to rapid commercialization that will benefit industry-leading companies like Cellular Dynamics International, Inc. (NASDAQ: ICEL), Athersys, Inc. (NASDAQ: ATHX) and Cytori Therapeutics, Inc. (NASDAQ: CYTX).
Cellular Dynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Fri Jan 10, 7:00AM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the 32 Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PST, Tuesday, January 14, at the Westin St. Francis Hotel in San Francisco.
Why You Must Watch Nestlé SA, Cellular Dynamics International Inc., AstraZeneca plc (ADR), and Arthr
Leo Sun, The Motley Fool - Motley Fool - Wed Jan 08, 6:58AM CST
Follow @leokornsun // full story)
Cellular Dynamics International to supply iCell and MyCell Products to NIHS for nutritional research
M2 - Wed Jan 08, 5:17AM CST
Stem cell technologies company Cellular Dynamics International (NasdaqGM:ICEL) revealed on Wednesday the execution of long-term supply agreement with the Nestle Institute of Health Sciences SA (NIHS) for an undisclosed amount.
Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research
Thomson Reuters ONE - Wed Jan 08, 1:00AM CST
MADISON, Wis., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced signing a long-term supply agreement with the Nestle Institute of Health Sciences SA (NIHS). Terms of the agreement were not disclosed.
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 16, 7:05AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 23, 2013.
The Hamner Institutes for Health Sciences partners with Cellular Dynamics to develop in vitro assays using human iPS cell-derived hepatocytes
M2 - Tue Dec 10, 4:49AM CST
Stem cell technologies company Cellular Dynamics International (NasdaqGM:CDI) reported on Monday the launch of a collaborative agreement to develop predictive in vitro screening assays for chemical, environmental and pharmaceutical toxicology assessments that utilise its human induced pluripotent stem (iPS) cell-derived hepatocytes.
The Hamner Institutes and Cellular Dynamics Collaborate to Develop In Vitro Assays Using Human iPS Cell-Derived Hepatocytes
GlobeNewswire - Mon Dec 09, 7:00AM CST
The Hamner Institutes for Health Sciences today announced a collaborative agreement with Cellular Dynamics International (CDI) to develop predictive in vitro screening assays for chemical, environmental and pharmaceutical toxicology assessments that utilize CDI's human induced pluripotent stem (iPS) cell-derived hepatocytes.
Jain Foundation Signs Agreement With Cellular Dynamics to Create iPSC Lines From Patients With Muscular Dystrophies
GlobeNewswire - Wed Dec 04, 7:00AM CST
The Jain Foundation, a non-profit organization whose mission is to cure muscular dystrophies caused by dysferlin protein deficiency, today announced the signing of a Master Service Agreement with Cellular Dynamics International (CDI) (Nasdaq:ICEL). CDI will create five induced pluripotent stem cell (iPSC) lines from patients with these dystrophies. As there are currently no effective treatments for these genetic disorders, establishing model iPSC lines is an important step toward developing new drugs and therapies for these patients. Terms of the agreement were not disclosed.
Cellular Dynamics International Reports Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 3:05PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the third quarter ended September 30, 2013.
Cellular Dynamics International Announces Conference Call to Discuss Third Quarter 2013 Financial and Operating Results
GlobeNewswire - Tue Nov 05, 7:00AM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced that it will report third quarter 2013 financial and operating results after the close of U.S. financial markets on November 12, 2013. Bob Palay, chairman of the board and chief executive officer of CDI, will host a conference call and webcast at 8:00 a.m. EST, November 13, 2013.
Cellular Dynamics Receives Formal Notice of Grant Award (NGA) for $16 Million Stem Cell Banking Project
GlobeNewswire - Mon Nov 04, 3:05PM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) announced today that the company has received the Notice of Grant Award (NGA) from the California Institute of Regenerative Medicine (CIRM) to create a human induced pluripotent stem cell (iPSC) biobank from 3,000 individuals. Receipt of the NGA signifies the entry into a definitive agreement with CIRM and the initiation of funding for the $16 million project.
(0)
(0)Cellular Dynamics International, Inc. (ICEL ) Stock Research Links
Scroll down for more posts ▼